Johnson JA - Search Results

1

Diabetes and cancer (2): evaluating the impact of diabetes on mortality in patients with cancer.

Renehan AG, Yeh HC, Johnson JA, Wild SH, Gale EA, Møller H; Diabetes and Cancer Research Consortium. Renehan AG, et al. Among authors: johnson ja. Diabetologia. 2012 Jun;55(6):1619-32. doi: 10.1007/s00125-012-2526-0. Epub 2012 Apr 4. Diabetologia. 2012. PMID: 22476948 Review.

2

Lack of insurance coverage for testing supplies is associated with poorer glycemic control in patients with type 2 diabetes.

Bowker SL, Mitchell CG, Majumdar SR, Toth EL, Johnson JA. Bowker SL, et al. Among authors: johnson ja. CMAJ. 2004 Jul 6;171(1):39-43. doi: 10.1503/cmaj.1031830. CMAJ. 2004. PMID: 15238494 Free PMC article.

3

Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin.

Bowker SL, Majumdar SR, Veugelers P, Johnson JA. Bowker SL, et al. Among authors: johnson ja. Diabetes Care. 2006 Feb;29(2):254-8. doi: 10.2337/diacare.29.02.06.dc05-1558. Diabetes Care. 2006. PMID: 16443869

4

A cross-sectional study of health-related quality of life deficits in individuals with comorbid diabetes and cancer.

Bowker SL, Pohar SL, Johnson JA. Bowker SL, et al. Among authors: johnson ja. Health Qual Life Outcomes. 2006 Mar 22;4:17. doi: 10.1186/1477-7525-4-17. Health Qual Life Outcomes. 2006. PMID: 16553957 Free PMC article.

5

Comment on: Evans JM, Ogston SA, Emslie-Smith A, Morris A (2006) risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin. Diabetologia 49:930-936.

Johnson JA, Simpson SH, Eurich DT, Majumdar SR. Johnson JA, et al. Diabetologia. 2006 Nov;49(11):2805-6. doi: 10.1007/s00125-006-0323-3. Epub 2006 Jun 21. Diabetologia. 2006. PMID: 16788800 No abstract available.

6

Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin: Response to Farooki and Schneider.

Bowker SL, Majumdar SR, Veugelers P, Johnson JA. Bowker SL, et al. Among authors: johnson ja. Diabetes Care. 2006 Aug;29(8):1990-1. doi: 10.2337/dc06-0997. Diabetes Care. 2006. PMID: 16873829 No abstract available.

7

Self-monitoring in Type 2 diabetes: a randomized trial of reimbursement policy.

Johnson JA, Majumdar SR, Bowker SL, Toth EL, Edwards A. Johnson JA, et al. Diabet Med. 2006 Nov;23(11):1247-51. doi: 10.1111/j.1464-5491.2006.01973.x. Diabet Med. 2006. PMID: 17054603 Clinical Trial.

8

Prospective study of hyperglycemia and cancer risk: response to Stattin et al.

Bowker SL, Johnson JA. Bowker SL, et al. Among authors: johnson ja. Diabetes Care. 2007 Jul;30(7):e77; author reply e78. doi: 10.2337/dc07-0544. Diabetes Care. 2007. PMID: 17596500 No abstract available.

9

Glucose-lowering agents and cancer mortality rates in type 2 diabetes: assessing effects of time-varying exposure.

Bowker SL, Yasui Y, Veugelers P, Johnson JA. Bowker SL, et al. Among authors: johnson ja. Diabetologia. 2010 Aug;53(8):1631-7. doi: 10.1007/s00125-010-1750-8. Epub 2010 Apr 21. Diabetologia. 2010. PMID: 20407744

10

Diabetes, insulin use, and cancer risk: are observational studies part of the solution-or part of the problem?

Johnson JA, Gale EA. Johnson JA, et al. Diabetes. 2010 May;59(5):1129-31. doi: 10.2337/db10-0334. Diabetes. 2010. PMID: 20427699 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,773 results

Search Page

Filters